BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12932598)

  • 1. Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
    Bojesen SE; Juul K; Schnohr P; Tybjaerg-Hansen A; Nordestgaard BG;
    J Am Coll Cardiol; 2003 Aug; 42(4):661-7. PubMed ID: 12932598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.
    O'Connor FF; Shields DC; Fitzgerald A; Cannon CP; Braunwald E; Fitzgerald DJ
    Blood; 2001 Dec; 98(12):3256-60. PubMed ID: 11719362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
    Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
    J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
    Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
    Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
    Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
    Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
    Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
    Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival.
    Oksala NK; Heikkinen M; Mikkelsson J; Pohjasvaara T; Kaste M; Erkinjuntti T; Karhunen PJ
    Stroke; 2007 Jan; 38(1):50-5. PubMed ID: 17138951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
    Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Feng D; Lindpaintner K; Larson MG; O'Donnell CJ; Lipinska I; Sutherland PA; Mittleman M; Muller JE; D'Agostino RB; Levy D; Tofler GH
    Circulation; 2001 Jul; 104(2):140-4. PubMed ID: 11447076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
    Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
    J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice.
    Di Castelnuovo A; de Gaetano G; Benedetta Donati M; Iacoviello L
    Am J Pharmacogenomics; 2005; 5(2):93-9. PubMed ID: 15813672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
    Carter AM; Ossei-Gerning N; Wilson IJ; Grant PJ
    Circulation; 1997 Sep; 96(5):1424-31. PubMed ID: 9315527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.
    Sethi AA; Tybjaerg-Hansen A; Grønholdt ML; Steffensen R; Schnohr P; Nordestgaard BG
    Ann Intern Med; 2001 May; 134(10):941-54. PubMed ID: 11352695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study.
    Aleksic N; Juneja H; Folsom AR; Ahn C; Boerwinkle E; Chambless LE; Wu KK
    Circulation; 2000 Oct; 102(16):1901-5. PubMed ID: 11034936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
    Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
    Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
    Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
    J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
    Papp E; Havasi V; Bene J; Komlosi K; Talian G; Feher G; Horvath B; Szapary L; Toth K; Melegh B
    Drugs Aging; 2007; 24(4):345-50. PubMed ID: 17432927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
    O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
    Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.